synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapyKyle B. Lupo, Sandro Matosevic|Nature Communications|2024Cited by 39
Engineered NKG2C <sup>+</sup> NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndromeKyle B. Lupo, Katharine C. Hsu|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 2